BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29580573)

  • 1. [Benign and malignant giant-cell rich lesions of bone: Pathological diagnosis with special emphasis on recent immunohistochemistry and molecular techniques].
    Macagno N; Caselles K; Aubert S; Audard V; Gomez-Brouchet A; Galant C; Guinebretière JM; Karanian M; Larousserie F; Marie B; de Pinieux G; Bouvier C
    Ann Pathol; 2018 Apr; 38(2):92-102. PubMed ID: 29580573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions.
    Shooshtarizadeh T; Rahimi M; Movahedinia S
    Pathol Res Pract; 2016 Oct; 212(10):876-879. PubMed ID: 27473669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pitfalls and typical false interpretations in bone tumors. From the viewpoint of long-term consultation].
    Salzer-Kuntschik M
    Pathologe; 1996 Jan; 17(1):1-5. PubMed ID: 8685089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma.
    Cleven AH; Höcker S; Briaire-de Bruijn I; Szuhai K; Cleton-Jansen AM; Bovée JV
    Am J Surg Pathol; 2015 Nov; 39(11):1576-83. PubMed ID: 26457357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chondroblastoma occurring in atypical sites].
    Jiang ZM; Zhang HZ; Tan YS; Tang RY; Liu HM; Lu SH; Shu MJ; Zeng BF; Yang SX; Chen JQ; Huang J
    Zhonghua Bing Li Xue Za Zhi; 2004 Dec; 33(6):503-7. PubMed ID: 15634443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell-rich histological mimics.
    Guimarães LM; Baumhoer D; Andrei V; Friedel D; Koelsche C; Gomez RS; von Deimling A; Gomes CC
    J Pathol Clin Res; 2023 Nov; 9(6):464-474. PubMed ID: 37555357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumors affecting the temporomandibular joint - a literature review].
    Schlund M; Roland-Billecart T; Aubert S; Nicot R
    Bull Cancer; 2020 Nov; 107(11):1186-1198. PubMed ID: 33059872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine needle aspiration diagnosis of aggressive giant cell tumor of bone. A case report.
    Ríos-Martín J; Otal-Salaverri C; Vázquez-Ramírez FJ; González-Cámpora R; Davidson HG
    Acta Cytol; 1995; 39(3):550-4. PubMed ID: 7762351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Giant cell-containing tumors of bone and differential diagnoses].
    Heitkötter B; Hartmann W
    Pathologe; 2022 May; 43(3):174-182. PubMed ID: 35467097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can p63 serve as a biomarker for giant cell tumor of bone? A Moroccan experience.
    Hammas N; Laila C; Youssef AL; Hind el F; Harmouch T; Siham T; Afaf A
    Diagn Pathol; 2012 Sep; 7():130. PubMed ID: 23016917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditions that mimic osteosarcoma.
    Raymond AK; Jaffe N
    Cancer Treat Res; 2009; 152():85-121. PubMed ID: 20213387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soft-tissue and bone tumors about the foot and ankle.
    Walling AK; Gasser SI
    Clin Sports Med; 1994 Oct; 13(4):909-38. PubMed ID: 7805113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.
    Schaefer IM; Fletcher JA; Nielsen GP; Shih AR; Ferrone ML; Hornick JL; Qian X
    Cancer Cytopathol; 2018 Aug; 126(8):552-566. PubMed ID: 29757500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases.
    Leinauer B; Wolf E; Werner M; Baumhoer D; Breining T; Luebke AM; Maas R; Schultheiß M; von Baer A; Sufi-Siavach A; Moritz C; Geißler S; Mellert K; Möller P; Barth TFE; Jundt G
    Histopathology; 2021 Nov; 79(5):720-730. PubMed ID: 33991114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p63 expression in giant cell-containing lesions of bone and soft tissue.
    de la Roza G
    Arch Pathol Lab Med; 2011 Jun; 135(6):776-9. PubMed ID: 21631272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential diagnosis of giant cell-rich lesions of bone].
    Lang S
    Pathologe; 2008 Nov; 29 Suppl 2():245-9. PubMed ID: 18836722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathology of giant cell tumors of the bone: With special emphasis on fibrohistiocytic and aneurysmal bone cyst like components.
    Çomunoğlu N; Kepil N; Dervişoğlu S
    Acta Orthop Traumatol Turc; 2019 Jan; 53(1):35-39. PubMed ID: 30392920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of SATB2 in the pathologic diagnosis of osteosarcoma].
    Li M; Cai YP; Lu KY; Chen Y; Zhu X; Yin Y; Tang J
    Zhonghua Bing Li Xue Za Zhi; 2016 Sep; 45(9):631-5. PubMed ID: 27646893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of P63 in Differentiating Giant Cell Tumor from Other Giant Cell-Containing Lesions.
    Hui M; Uppin SG; Kumar KK; Radhika S; Chandrasekhar P; Rao KN
    Turk Patoloji Derg; 2022; 38(1):9-15. PubMed ID: 34514571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Giant-cell tumor of bone in 2022].
    Larousserie F; Audard V; Burns R; de Pinieux G
    Ann Pathol; 2022 Apr; 42(3):214-226. PubMed ID: 35523609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.